NEW YORK (GenomeWeb) – 908 Devices today announced that it has raised an additional $1.4 million as part of a Series C round of financing, bringing the total raised in the round to $13 million.

The latest fundraising included investments from Casdin Capital, as well as Ortho Clinical Diagnostics Chairman and CEO Martin Madaus and former Thermo Fisher Scientific Chairman Paul Meister, among others.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.